Department of Health and Social Care
Three quarters of UK adults vaccinated with first dose
Milestone reached as Health and Social Care Secretary gives a speech marking almost 6 months since unprecedented vaccination programme began.
- Over three quarters of UK adults have been vaccinated with a first dose of the COVID-19 vaccine
- Public urged to come forward for second doses to help protect against the threat of new variants
More than three quarters of UK adults have received a first dose of a COVID-19 vaccine, the latest figures show, as the vaccination programme continues at pace.
Health services across the UK have now administered over 65.6 million vaccines between 8 December and 1 June, including over 39.5 million people with their first dose (75.2%) and over 26 million with both doses (49.5%), ensuring they have the strongest possible protection against COVID-19 from a second dose.
This week, G7 health ministers will gather ahead of the leader’s summit where the Health Secretary will praise the fantastic efforts of the NHS, volunteers, and scientists over the last year in developing and rolling out the vaccine programme at pace.
The G7 Health Ministers’ summit follows the announcement last week that Janssen’s single-dose COVID-19 vaccine has been authorised for use by the UK medicines regulator, the MHRA. This is yet another weapon in the UK’s fight against the pandemic. Earlier this year, the Janssen vaccine was shown to be 67% effective overall in preventing COVID-19 infection and 85% effective in preventing severe disease or hospitalisation.
Health and Social Care Secretary Matt Hancock said:
I am incredibly pleased that over three quarters of UK adults have had their first dose. This is an incredible step forward in the largest and most successful vaccination programme in our history.
Although we’ve come so far in less than 6 months since the world’s first authorised jab was given in the UK, our vital work is not done. We must redouble our efforts on the second dose to ensure as many people as possible have maximum protection.
We’ve brought forward appointments from 12 to 8 weeks for a second dose, and all over 30s are now eligible for the jab. I encourage everyone to come forward when the offer comes and play a part in getting us back to normality.
Vaccines Minister Nadhim Zahawi said:
Three quarters of adults have been vaccinated with a first dose of the vaccine, a remarkable milestone.
I want to pay tribute to everyone involved who has helped deliver the vaccine into arms at record speed – the NHS and care staff, volunteers, pharmacists, civil servants and more – this was truly a momentous national effort.
The second dose is crucial to get maximum protection so please come forward for your second jab. It could save your life and protect your loved ones.
The government met its target of offering a vaccine to the most vulnerable by 15 April and remains on track to offer a first dose to all adults by the end of July, as well as vaccinating all adults over 50 with both doses by 21 June. NHS England has extended the offer of a vaccine to everyone over the age of 30, and people are encouraged to come forward and get their jab when called.
To ensure people have the strongest possible protection against COVID-19, appointments for second doses have been brought forward from 12 to 8 weeks for the remaining people in the top 9 priority groups who have yet to receive both doses.
The move follows updated advice from the independent experts at the Joint Committee on Vaccination and Immunisation (JCVI), which has considered the latest available evidence and has recommended reducing the dosing interval to counter the threat of new variants of concern. The government and its scientific experts are monitoring the evolving situation and rates of variants closely, and will not hesitate to take additional action as necessary.
A recent study by Public Health England (PHE) shows that 2 doses of the COVID-19 vaccines are highly effective against the B.1.617.2 variant first identified in India. Vaccine effectiveness against symptomatic disease from the B.1.617.2 variant is similar after 2 doses compared to the B.1.1.7 (Kent) variant dominant in the UK, and we expect to see even higher levels of effectiveness against hospitalisation and death.
Secretary of State for Scotland Alister Jack said:
This is further great news and shows just how hugely successful the UK government vaccination programme is.
We have procured and paid for millions of doses for people in all parts of the UK. With 4 vaccines now approved, and the rollout going well, we can all feel hopeful for the future.
The fight against COVID isn’t over but, working as a team – from our amazing health workers, to the military, to everyone getting their jab when it’s offered – the UK can beat this cruel pandemic.
Secretary of State for Wales Simon Hart said:
To have reached the milestone of over three quarters of UK adults having had their first dose of a vaccine is a remarkable achievement.
We have come impressively far in the last 6 months and my thanks go to all the dedicated and tireless individuals that have contributed their vital support to the national vaccine delivery effort.
While we celebrate, there is still work yet to be done as we increase our efforts to ensure that lives are protected. I encourage you all to come forward when called and help us continue on our journey back to normality.
Secretary of State for Northern Ireland Brandon Lewis said:
This is fantastic news! Thanks to all the healthcare workers, armed forces, civil servants and volunteers who have helped us reach this milestone – a tremendous effort by all.
We have come so far but it is vitally important to attend your second vaccine appointment and receive your second dose – it will give you and those around you the best possible protection.
Vaccinated people are far less likely to get COVID-19 with symptoms. Vaccinated people are even more unlikely to get serious COVID-19, to be admitted to hospital, or to die from it and there is growing evidence that vaccinated people are less likely to pass the virus to others.
Data from PHE’s real-world study shows the vaccines are already having a significant impact in the UK, reducing hospitalisations and deaths, saving more than 13,200 lives and preventing at least 39,700 hospitalisations in England.
PHE analysis also shows that individuals who receive a single dose of the Oxford/AstraZeneca vaccine have approximately 80% lower risk of death against the B.1.1.7 coronavirus variant originating in Kent and a second dose of the vaccine can provide 85 to 90% protection against symptomatic disease. Protection against death from the Pfizer-BioNTech vaccine rises from approximately 80% after one dose to 97% after 2 doses against the Kent variant.
Data published by YouGov shows the UK continues to top the list of nations where people are willing to have a COVID-19 vaccine or have already been vaccinated. ONS data published on 6 May found that more than 9 in 10 (93%) adults reported positive sentiment towards the vaccine.
Approved vaccines are available from thousands of NHS vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England and vaccinations are taking place at sites including mosques, community centres and football stadiums.
See the latest UK-wide vaccination statistics and NHS England vaccine statistics for England.
See PHE’s real-world data on the efficacy of COVID-19 vaccines. Read their latest study on household transmission.
See the YouGov data comparing uptake rates in countries around the world.
To date, the government has invested over £300 million into manufacturing a successful vaccine to enable a rapid roll out.
The UK government is committed to supporting equitable access to vaccines worldwide. The UK is one of the largest donors to the COVAX facility, the global mechanism to help developing countries access a coronavirus vaccine, and has committed £548 million in UK aid to help distribute 1.3 billion doses of coronavirus vaccines to 92 developing countries this year.
Original article link: https://www.gov.uk/government/news/three-quarters-of-uk-adults-vaccinated-with-first-dose
Latest News from
Department of Health and Social Care
Increased funding for care homes providing nursing29/03/2023 12:10:00
Additional funds will help cover the costs of nursing care, ensuring the vital service can continue to support the needs of residents who rely on it.
Life sciences companies supercharged with £277 million in government and private investment28/03/2023 13:12:00
Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants.
Government sets out strategy to protect NHS from cyber attacks22/03/2023 11:15:00
The government will provide a plan to promote cyber resilience across the health and care sectors by 2030, protecting both services and patients.
Sector leaders to drive progress on national Dame Barbara Windsor Mission to beat dementia20/03/2023 11:27:00
The UK Government has named two leaders in dementia research to spearhead the ambitious national Mission to tackle dementia.
Temporary border measures to enhance Covid surveillance from China removed17/03/2023 15:25:00
Precautionary and temporary measures introduced in January to improve the UK’s ability to detect potential new variants of Covid from China are being removed.
Hundreds of thousands of women experiencing menopause symptoms to get cheaper HRT17/03/2023 12:20:00
Around 400,000 women across England will get better access to menopause support - saving hundreds of pounds and making treatment more accessible.
Government and Health Unions agree pay deal paving way for an end to strike action16/03/2023 16:30:00
After constructive talks with Health Unions, the government has put forward an offer for more than 1 million NHS staff to receive an additional pay rise
MHRA trialling pioneering stem cell robot that could transform the availability of life-saving cell therapies16/03/2023 14:10:00
The MHRA’s UK Stem Cell Bank is one of only two places in the world to test this technology.